Kumru Sahin Gizem, Unterrainer Christian, Süsal Caner
Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.
Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.
Transplant Rev (Orlando). 2020 Apr;34(2):100533. doi: 10.1016/j.trre.2020.100533. Epub 2020 Jan 17.
Human leukocyte antigen (HLA) matching is one of the cornerstones of organ allocation in deceased-donor kidney transplantation. Increased numbers of HLA allele mismatches are associated with a higher risk of immunological rejection, de novo donor-specific HLA antibody development and graft failure. HLA epitopes are defined as the specific portions of HLA molecules to which antibodies and T-cell receptors bind with their paratopes. The same epitope can be present on different HLA alleles. Therefore, HLA matching at the epitope instead of allele level theoretically offers a more precise assessment of donor-recipient HLA compatibility and may more effectively prevent sensitization against foreign tissue. In this review, we describe the different options proposed to define clinically relevant HLA epitopes and critically discuss the potential role of HLA epitope matching in kidney transplantation.
人类白细胞抗原(HLA)配型是尸体供肾移植中器官分配的基石之一。HLA等位基因错配数量增加与免疫排斥、新发供者特异性HLA抗体产生及移植肾失功风险升高相关。HLA表位被定义为HLA分子上能与抗体和T细胞受体的互补位结合的特定部分。同一表位可存在于不同的HLA等位基因上。因此,从表位水平而非等位基因水平进行HLA配型理论上能更精确地评估供受者HLA相容性,并可能更有效地预防对外来组织的致敏。在本综述中,我们描述了为定义临床相关HLA表位而提出的不同方法,并批判性地讨论了HLA表位配型在肾移植中的潜在作用。